HEADER HYDROLASE/HYDROLASE INHIBITOR 14-NOV-03 1RHQ TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A TITLE 2 BROMOMETHOXYPHENYL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: P17 SUBUNIT; COMPND 5 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN, COMPND 6 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 7 EC: 3.4.22.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-3; COMPND 11 CHAIN: B, E; COMPND 12 FRAGMENT: P12 SUBUNIT; COMPND 13 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN, COMPND 14 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 15 EC: 3.4.22.-; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: CASP3, CPP32; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.W.BECKER,J.ROTONDA,S.M.SOISSON REVDAT 9 13-MAR-24 1RHQ 1 COMPND SOURCE REVDAT 8 20-SEP-23 1RHQ 1 REMARK REVDAT 7 21-DEC-22 1RHQ 1 REMARK SEQADV LINK REVDAT 6 11-OCT-17 1RHQ 1 REMARK REVDAT 5 22-JAN-14 1RHQ 1 MTRIX1 MTRIX2 MTRIX3 REVDAT 4 13-JUL-11 1RHQ 1 VERSN REVDAT 3 12-MAY-09 1RHQ 1 MTRIX1 MTRIX2 MTRIX3 REVDAT 2 24-FEB-09 1RHQ 1 VERSN REVDAT 1 11-MAY-04 1RHQ 0 JRNL AUTH J.W.BECKER,J.ROTONDA,S.M.SOISSON,R.ASPIOTIS,C.BAYLY, JRNL AUTH 2 S.FRANCOEUR,M.GALLANT,M.GARCIA-CALVO,A.GIROUX,E.GRIMM,Y.HAN, JRNL AUTH 3 D.MCKAY,D.W.NICHOLSON,E.PETERSON,J.RENAUD,S.ROY, JRNL AUTH 4 N.THORNBERRY,R.ZAMBONI JRNL TITL REDUCING THE PEPTIDYL FEATURES OF CASPASE-3 INHIBITORS: A JRNL TITL 2 STRUCTURAL ANALYSIS. JRNL REF J.MED.CHEM. V. 47 2466 2004 JRNL REFN ISSN 0022-2623 JRNL PMID 15115390 JRNL DOI 10.1021/JM0305523 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 19655.730 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.4 REMARK 3 NUMBER OF REFLECTIONS : 9964 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.273 REMARK 3 R VALUE (WORKING SET) : 0.273 REMARK 3 FREE R VALUE : 0.354 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1020 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 9964 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1312 REMARK 3 BIN R VALUE (WORKING SET) : 0.3490 REMARK 3 BIN FREE R VALUE : 0.4110 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3740 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.56000 REMARK 3 B22 (A**2) : 2.42000 REMARK 3 B33 (A**2) : -8.97000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.48000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM SIGMAA (A) : 0.62 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.62 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.75 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 6.100 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 9.470 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 7.300 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 10.780; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.18 REMARK 3 BSOL : 10.00 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : PARAM.ICE REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : TOP_NEW.ICE REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1RHQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1000020752. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-APR-98 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 4.93 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : SAINT V. 4.050 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11487 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.999 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 1.390 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.20 REMARK 200 R MERGE FOR SHELL (I) : 0.16300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.030 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PROTEIN PART OF 1PAU.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7.8% PEG-6000, 100 MM CITRATE, 120 MM REMARK 280 ZNCL(2), 10 MM DTT, 3 MM NAN(3), PH 4.93, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 55.15000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.45000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 55.15000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 48.45000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL ASSEMBLY. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -74.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 145 REMARK 465 GLY A 146 REMARK 465 ILE A 147 REMARK 465 SER A 148 REMARK 465 LEU A 149 REMARK 465 THR A 296 REMARK 465 ASP A 297 REMARK 465 SER B 310 REMARK 465 GLY B 311 REMARK 465 VAL B 312 REMARK 465 ASP B 313 REMARK 465 ASP B 314 REMARK 465 ASP B 315 REMARK 465 MET B 316 REMARK 465 ALA B 317 REMARK 465 CYS B 318 REMARK 465 HIS B 319 REMARK 465 HIS B 402 REMARK 465 SER D 145 REMARK 465 GLY D 146 REMARK 465 ILE D 147 REMARK 465 SER D 148 REMARK 465 LEU D 149 REMARK 465 THR D 296 REMARK 465 ASP D 297 REMARK 465 SER E 310 REMARK 465 GLY E 311 REMARK 465 VAL E 312 REMARK 465 ASP E 313 REMARK 465 ASP E 314 REMARK 465 ASP E 315 REMARK 465 MET E 316 REMARK 465 ALA E 317 REMARK 465 CYS E 318 REMARK 465 HIS E 319 REMARK 465 HIS E 402 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 239 OE2 GLU A 239 2758 0.72 REMARK 500 NE2 HIS D 174 OD1 ASP E 381E 2758 1.49 REMARK 500 O GLY A 175C O GLY A 175C 2758 1.54 REMARK 500 CA GLY A 175C CG2 THR A 177 2758 1.83 REMARK 500 CD GLU A 239 OE2 GLU A 239 2758 1.92 REMARK 500 CE1 HIS D 174 OD1 ASP E 381E 2758 1.98 REMARK 500 NE2 HIS D 174 CG ASP E 381E 2758 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 156 42.68 -157.62 REMARK 500 PRO A 161 -13.33 -48.51 REMARK 500 LYS A 171 -44.33 -149.51 REMARK 500 ARG A 179 79.64 -105.66 REMARK 500 SER A 180 93.48 -58.01 REMARK 500 ASP A 185 -85.45 -52.64 REMARK 500 ALA A 186 -35.80 -27.34 REMARK 500 ASP A 205 63.01 25.72 REMARK 500 GLU A 209 39.38 -83.89 REMARK 500 GLU A 210 -42.62 -142.70 REMARK 500 MET A 215 -70.90 -53.45 REMARK 500 SER A 229 -173.72 177.79 REMARK 500 SER A 236 -159.13 179.76 REMARK 500 HIS A 237 -168.62 -109.75 REMARK 500 ILE A 243 126.40 -172.62 REMARK 500 THR A 246 30.26 -84.64 REMARK 500 ASN A 247 -34.96 -149.38 REMARK 500 LYS A 260 10.78 -66.58 REMARK 500 PHE A 264 -3.83 -57.95 REMARK 500 ARG A 269 -75.34 -76.24 REMARK 500 THR A 288 37.63 -146.94 REMARK 500 ASP B 326 12.40 81.66 REMARK 500 SER B 343 -9.58 -55.43 REMARK 500 LYS B 344 -72.54 -114.35 REMARK 500 SER B 347 133.61 -37.67 REMARK 500 TRP B 348 -74.38 -50.10 REMARK 500 ALA B 361 8.32 -56.31 REMARK 500 ASP B 362 15.82 -141.69 REMARK 500 GLU B 365 -108.60 -92.14 REMARK 500 PHE B 366 -49.67 -154.19 REMARK 500 LYS B 376 13.61 -68.40 REMARK 500 ALA B 382 52.28 75.06 REMARK 500 PHE B 400 71.00 -63.01 REMARK 500 ASP D 156 42.63 -157.65 REMARK 500 PRO D 161 -13.30 -48.56 REMARK 500 LYS D 171 -44.36 -149.49 REMARK 500 ARG D 179 79.65 -105.65 REMARK 500 SER D 180 93.46 -57.97 REMARK 500 ASP D 185 -85.47 -52.62 REMARK 500 ALA D 186 -35.76 -27.37 REMARK 500 ASP D 205 63.00 25.72 REMARK 500 GLU D 209 39.43 -83.91 REMARK 500 GLU D 210 -42.60 -142.74 REMARK 500 MET D 215 -70.83 -53.49 REMARK 500 SER D 229 -173.69 177.82 REMARK 500 SER D 236 -159.12 179.77 REMARK 500 HIS D 237 -168.63 -109.76 REMARK 500 ILE D 243 126.44 -172.63 REMARK 500 THR D 246 30.25 -84.58 REMARK 500 ASN D 247 -35.00 -149.35 REMARK 500 REMARK 500 THIS ENTRY HAS 66 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR BINDS TO THE CATALYTIC CYS 285 IN CHAINS REMARK 600 A AND D VIA HEMITHIOACETAL LINKAGES REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: 5-S-BENZYL-3-({N-[(5-BROMO-2-METHOXYPHENYL)ACETYL]- REMARK 630 L-VALYL}AMINO)-2,3-DIDEOXY-5-THIO-D-ERYTHRO-PENTONIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0ZZ A 551 REMARK 630 0ZZ D 551 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: IRA VAL RH0 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZZ A 551 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZZ D 551 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PAU RELATED DB: PDB REMARK 900 CASPASE-3 COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-ALDEHYDE REMARK 900 RELATED ID: 1RHJ RELATED DB: PDB REMARK 900 RELATED ID: 1RHK RELATED DB: PDB REMARK 900 RELATED ID: 1RHM RELATED DB: PDB REMARK 900 RELATED ID: 1RHR RELATED DB: PDB REMARK 900 RELATED ID: 1RHU RELATED DB: PDB DBREF 1RHQ A 145 297 UNP P42574 ICE3_HUMAN 29 175 DBREF 1RHQ D 145 297 UNP P42574 ICE3_HUMAN 29 175 DBREF 1RHQ B 310 402 UNP P42574 ICE3_HUMAN 176 277 DBREF 1RHQ E 310 402 UNP P42574 ICE3_HUMAN 176 277 SEQADV 1RHQ GLU B 324 UNP P42574 ASP 190 VARIANT SEQADV 1RHQ GLU E 324 UNP P42574 ASP 190 VARIANT SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 147 ILE GLU THR ASP SEQRES 1 B 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 102 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS SEQRES 1 D 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 D 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 D 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 D 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 D 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 D 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 D 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 D 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 D 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 D 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 D 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 D 147 ILE GLU THR ASP SEQRES 1 E 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 E 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 E 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 E 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 E 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 E 102 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 E 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 E 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS HET 0ZZ A 551 36 HET 0ZZ D 551 36 HETNAM 0ZZ 5-S-BENZYL-3-({N-[(5-BROMO-2-METHOXYPHENYL)ACETYL]-L- HETNAM 2 0ZZ VALYL}AMINO)-2,3-DIDEOXY-5-THIO-D-ERYTHRO-PENTONIC HETNAM 3 0ZZ ACID FORMUL 5 0ZZ 2(C26 H33 BR N2 O6 S) HELIX 1 1 HIS A 174 GLY A 175C 5 5 HELIX 2 2 GLY A 181 PHE A 193 1 13 HELIX 3 3 ARG A 194 LYS A 197 5 4 HELIX 4 4 THR A 207 LYS A 220 1 14 HELIX 5 5 LEU A 258 ASN A 263 1 6 HELIX 6 6 PHE A 264 ARG A 266 5 3 HELIX 7 7 SER B 347 TYR B 360 1 14 HELIX 8 8 PHE B 366 THR B 379 1 14 HELIX 9 9 ASP B 381E HIS B 381I 5 5 HELIX 10 10 HIS D 174 GLY D 175C 5 5 HELIX 11 11 GLY D 181 PHE D 193 1 13 HELIX 12 12 ARG D 194 LYS D 197 5 4 HELIX 13 13 THR D 207 LYS D 220 1 14 HELIX 14 14 LEU D 258 ASN D 263 1 6 HELIX 15 15 PHE D 264 ARG D 266 5 3 HELIX 16 16 SER E 347 TYR E 360 1 14 HELIX 17 17 PHE E 366 THR E 379 1 14 HELIX 18 18 ASP E 381E HIS E 381I 5 5 SHEET 1 A12 LYS A 203 ASN A 204 0 SHEET 2 A12 ILE A 168 ASN A 169 1 N ASN A 169 O LYS A 203 SHEET 3 A12 LEU A 234 LEU A 235 1 O LEU A 235 N ILE A 168 SHEET 4 A12 LYS A 278 GLN A 283 1 O ILE A 281 N LEU A 234 SHEET 5 A12 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280 SHEET 6 A12 CYS B 388 SER B 392 -1 O VAL B 390 N TYR B 329 SHEET 7 A12 CYS E 388 SER E 392 -1 O ILE E 389 N SER B 392 SHEET 8 A12 PHE E 327 TYR E 331 -1 N TYR E 329 O VAL E 390 SHEET 9 A12 LYS D 278 GLN D 283 1 N PHE D 280 O LEU E 328 SHEET 10 A12 LEU D 234 LEU D 235 1 N LEU D 234 O ILE D 281 SHEET 11 A12 ILE D 168 ASN D 169 1 N ILE D 168 O LEU D 235 SHEET 12 A12 LYS D 203 ASN D 204 1 O LYS D 203 N ASN D 169 SHEET 1 B 8 PHE A 230 VAL A 231 0 SHEET 2 B 8 LYS A 278 GLN A 283 1 O LEU A 279 N PHE A 230 SHEET 3 B 8 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280 SHEET 4 B 8 CYS B 388 SER B 392 -1 O VAL B 390 N TYR B 329 SHEET 5 B 8 CYS E 388 SER E 392 -1 O ILE E 389 N SER B 392 SHEET 6 B 8 PHE E 327 TYR E 331 -1 N TYR E 329 O VAL E 390 SHEET 7 B 8 LYS D 278 GLN D 283 1 N PHE D 280 O LEU E 328 SHEET 8 B 8 PHE D 230 VAL D 231 1 N PHE D 230 O LEU D 279 SHEET 1 C 2 ILE A 242 PHE A 244 0 SHEET 2 C 2 PRO A 255 ASP A 257 -1 O VAL A 256 N ILE A 243 SHEET 1 D 2 GLY A 287 GLU A 289 0 SHEET 2 D 2 GLY B 336 TYR B 337 1 O GLY B 336 N GLU A 289 SHEET 1 E 2 ILE D 242 PHE D 244 0 SHEET 2 E 2 PRO D 255 ASP D 257 -1 O VAL D 256 N ILE D 243 SHEET 1 F 2 GLY D 287 GLU D 289 0 SHEET 2 F 2 GLY E 336 TYR E 337 1 O GLY E 336 N GLU D 289 LINK SG CYS A 285 C9 0ZZ A 551 1555 1555 1.81 LINK SG CYS D 285 C9 0ZZ D 551 1555 1555 1.81 SITE 1 AC1 13 ARG A 179 SER A 236 HIS A 237 GLY A 238 SITE 2 AC1 13 GLU A 239 PHE A 244 CYS A 285 TYR B 338 SITE 3 AC1 13 SER B 339 TRP B 340 ARG B 341 SER B 381A SITE 4 AC1 13 PHE B 381B SITE 1 AC2 13 ARG D 179 SER D 236 HIS D 237 GLY D 238 SITE 2 AC2 13 GLU D 239 PHE D 244 CYS D 285 TYR E 338 SITE 3 AC2 13 SER E 339 TRP E 340 ARG E 341 SER E 381A SITE 4 AC2 13 PHE E 381B CRYST1 110.300 96.900 70.900 90.00 128.06 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009066 0.000000 0.007099 0.00000 SCALE2 0.000000 0.010320 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017913 0.00000 MTRIX1 1 1.000000 0.000000 0.000000 0.00000 1 MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 1 0.000000 0.000000 1.000000 0.00000 1 MTRIX1 2 0.227930 -0.007849 0.973646 -47.63420 1 MTRIX2 2 -0.007261 -0.999953 -0.006361 16.08090 1 MTRIX3 2 0.973651 -0.005619 -0.227976 60.25840 1